Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays

Martin J Garland, Katarzyna Migalska, Tuan-Mazlelaa Tuan-Mahmood, Thakur Raghu Raj Singh, Rita Majithija, Ester Caffarel-Salvador, Cian M McCrudden, Helen O McCarthy, A David Woolfson, Ryan F Donnelly

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)

Abstract

A plethora of studies have described the in vitro assessment of dissolving microneedle (MN) arrays for enhanced transdermal drug delivery, utilising a wide variety of model membranes as a representation of the skin barrier. However, to date, no discussion has taken place with regard to the choice of model skin membrane and the impact this may have on the evaluation of MN performance. In this study, we have, for the first time, critically assessed the most common types of in vitro skin permeation models - a synthetic hydrophobic membrane (Silescol(®) of 75 µm) and neonatal porcine skin of definable thickness (300-350 µm and 700-750 µm) - for evaluating the performance of drug loaded dissolving poly (methyl vinyl ether co maleic acid) (PMVE/MA) MN arrays. It was found that the choice of in vitro skin model had a significant effect on the permeation of a wide range of small hydrophilic molecules released from dissolving MNs. For example, when Silescol(®) was used as the model membrane, the cumulative percentage permeation of methylene blue 24h after the application of dissolvable MNs was found to be only approximately 3.7% of the total methylene blue loaded into the MN device. In comparison, when dermatomed and full thickness neonatal porcine skin were used as a skin model, approximately 67.4% and 47.5% of methylene blue loaded into the MN device was delivered across the skin 24h after the application of MN arrays, respectively. The application of methylene blue loaded MN arrays in a rat model in vivo revealed that the extent of MN-mediated percutaneous delivery achieved was most similar to that predicted from the in vitro investigations employing dermatomed neonatal porcine skin (300-350 µm) as the model skin membrane. On the basis of these results, a wider discussion within the MN community will be necessary to standardise the experimental protocols used for the evaluation and comparison of MN devices.
Original languageEnglish
Pages (from-to)80-9
Number of pages10
JournalInternational Journal of Pharmaceutics
Volume434
Issue number1-2
DOIs
Publication statusPublished - 2012

Bibliographical note

Copyright © 2012 Elsevier B.V. All rights reserved.

Fingerprint Dive into the research topics of 'Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays'. Together they form a unique fingerprint.

Cite this